Home » FDA Told to Clarify Dispute-Handling Policies
FDA Told to Clarify Dispute-Handling Policies
HHS’ inspector general’s office recommended that the Food and Drug Administration better define the way it documents and resolves scientific disagreements between medical-device reviewers and managers.
ModernHealthcare
ModernHealthcare
Upcoming Events
-
07May
-
14May
-
30May